Back

Implication of the new EHRA practical guide for the treatment of atrial fibrillation patients.

26 August 2018 (13:20 - 13:35)
Organised by:
Congress Presentation Part of: Oral anticoagulation in atrial fibrillation - From evidence-based medicine to daily clinical practice Treatment ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Jan Steffel

Klinik Hirslanden, Zurich (Switzerland)

5 More presentations in this session

Presentation thumbnail
Introduction - Oral anticoagulation in atrial fibrillation - From evidence-based medicine to daily clinical practice.
Doctor J. Weitz (Hamilton, CA)
Presentation thumbnail
Safety of non-vitamin K antagonist oral anticoagulants - Considerations for management of atrial fibrillation patients .
Doctor C. Ruff (Boston, US)
Presentation thumbnail
Complementing results from randomised trials: the value of international observational studies.
Professor P. Kirchhof (Hamburg, DE)
Presentation thumbnail
Panel discussion - Oral anticoagulation in atrial fibrillation - From evidence-based medicine to daily clinical practice
Doctor J. Weitz (Hamilton, CA)
Presentation thumbnail
Summary and close - Oral anticoagulation in atrial fibrillation - From evidence-based medicine to daily clinical practice.
Professor P. Kirchhof (Hamburg, DE)

Access the full session

Session thumbnail
Oral anticoagulation in atrial fibrillation - From evidence-based medicine to daily clinical practice

The Event

Event poster

ESC Congress 2018

26 August 2018 13:20 CET
You may be interested in
thumbnail
Congress Presentation
AF-CARE: “R” Rate and rhythm control
1 September 2024
thumbnail
Congress Presentation
Edoxaban treatment in real-world practice is highly concordant with ESC atrial fibrillation guidelines: results from the non-interventional global ETNA-AF program
27 August 2021
thumbnail
Congress Presentation
Generalizability of the EAST-AFNET 4 trial: assessing outcomes of early rhythm-control therapy in patients with atrial fibrillation
27 August 2021
thumbnail
Congress Presentation
Left atrial thrombus in heart failure patients undergoing elective electrical cardioversion despite guideline-recommended anticoagulation: prevalence, predictors and prognosis
12 April 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources